Vibe Coding Moves Beyond the Proteomics Prototype
-
By
-
James Strachan
-
September 30, 2026
-
14 min
By
James Strachan
September 30, 2026
In the single-arm REFOCUS trial, 46% of patients responded to treatment, with a median response duration of 11.8 months.
September 24, 2026
A microneedle platform captured a kidney injury biomarker from interstitial fluid
September 22, 2026